Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

IOVA US Equity

Iovance Biotherapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1425205 · FY ends Dec 31
$7.99
+0.96 (+13.66%)
USD · as of 2026-08-19 · marketstack
11 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-08-068-K 8.01Other eventssec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-028-K 8.01Other eventssec.gov ↗
2026-06-108-K 8.01Other eventssec.gov ↗
2026-06-108-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-1213GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-05-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-208-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-02-248-K 8.01Other eventssec.gov ↗
2026-02-248-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-0913GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-01-098-K 8.01Other eventssec.gov ↗
2025-11-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-08-298-K 8.01Other eventssec.gov ↗
2025-08-228-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-08-22

Every row is a filed document, checked against its EDGAR index.